Alnylam Licenses siRNA Patents to Japanese Distributor Hayashi Kasei | GenomeWeb
NEW YORK (GenomeWeb News) — Alnylam said today it has granted a non-exclusive license for its Kreutzer-Limmer siRNA patents to Hayashi Kasei, an siRNA supplier in Japan and Korea.
 
Under the agreement, the Osaka, Japan-based Hayashi Kasei will be able to use the siRNAi patents to provide RNAi research products and services, Alnylam said.
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.